Boston Scientific's latest marketcap:
As of 07/30/2025, Boston Scientific's market capitalization has reached $157.52 B. According to our data, Boston Scientific is the 106th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 157.52 B |
Revenue (ttm) | 18.49 B |
Net Income (ttm) | 2.5 B |
Shares Out | 1.48 B |
EPS (ttm) | 1.68 |
Forward PE | 34.25 |
Ex-Dividend Date | n/a |
Earnings Date | 07/23/2025 |
Boston Scientific's yearly market capitalization.
Date | Market Cap($) | Change (%) | Global Rank |
---|---|---|---|
07/30/2025 | $157.52 B | 18.95% | 106 |
12/31/2024 | $131.64 B | 55.44% | 119 |
12/29/2023 | $84.69 B | 27.79% | 170 |
12/30/2022 | $66.27 B | 9.48% | 208 |
12/31/2021 | $60.53 B | 17.59% | 294 |
12/31/2020 | $51.48 B | -18.33% | 302 |
12/31/2019 | $63.03 B | 28.88% | 184 |
12/31/2018 | $48.9 B | 43.66% | 199 |
12/29/2017 | $34.04 B | 15.58% | 375 |
12/30/2016 | $29.45 B | 18.74% | 342 |
Company Profile
About Boston Scientific Corporation
Boston Scientific Corporation is a global leader in developing, manufacturing, and marketing medical devices for interventional medical specialties. Headquartered in Marlborough, Massachusetts, the company was founded in 1979 and operates through two primary segments: MedSurg and Cardiovascular.
Key Product Offerings
- MedSurg Segment:
- Gastrointestinal solutions, including resolution clips, biliary stent systems, and single-use duodenoscopes.
- Urological devices such as ureteral stents, catheters, and laser systems.
- Neurological products for chronic pain management, including spinal cord stimulators and deep brain stimulation systems.
- Cardiovascular Segment:
- Technologies for coronary artery disease and aortic valve conditions.
- WATCHMAN FLX, a left atrial appendage closure (LAAC) device.
- Implantable cardiac devices like defibrillators, pacemakers, and remote monitoring systems.
Additional Specialties
The company also provides solutions for:
- Peripheral arterial and venous diseases.
- Diagnosis and treatment of cardiac rhythm disorders.
- Oncology products for cancer diagnosis and treatment.
Boston Scientific continues to innovate in medical technology, improving patient outcomes across a wide range of conditions.
Frequently Asked Questions
-
What is Boston Scientific's (BSX) current market cap?As of 07/30/2025, Boston Scientific (including the parent company, if applicable) has an estimated market capitalization of $157.52 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Boston Scientific (BSX) rank globally by market cap?Boston Scientific global market capitalization ranking is approximately 106 as of 07/30/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.